Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
14.59
-0.70 (-4.58%)
At close: Apr 28, 2026, 4:00 PM EDT
14.60
+0.01 (0.07%)
Pre-market: Apr 29, 2026, 6:38 AM EDT
Olema Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,272 | 1,966 | 430 | 766 | 98 | 372 | |
| Market Cap Growth | 393.61% | 357.26% | -43.88% | 679.84% | -73.58% | -79.78% | |
| Enterprise Value | 770 | 1,642 | 217 | 492 | -122 | 66 | |
| Last Close Price | 14.59 | 25.00 | 5.83 | 14.03 | 2.45 | 9.36 | |
| PB Ratio | 2.48 | 4.11 | 1.05 | 3.02 | 0.50 | 1.31 | |
| P/TBV Ratio | 2.66 | 4.11 | 1.05 | 3.02 | 0.50 | 1.31 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.05 | -1.05 | -1.06 | -1.02 | -1.02 | -1.00 | |
| Net Debt / EBITDA Ratio | 2.98 | 2.98 | 3.16 | 2.48 | 1.89 | 3.98 | |
| Net Debt / FCF Ratio | 3.42 | 3.42 | 4.14 | 3.10 | 2.45 | 5.43 | |
| Quick Ratio | 9.84 | 9.84 | 10.45 | 12.14 | 12.37 | 31.86 | |
| Current Ratio | 9.95 | 9.95 | 10.50 | 12.33 | 12.62 | 32.23 | |
| Return on Equity (ROE) | -36.61% | -36.61% | -39.06% | -42.82% | -43.47% | -22.83% | |
| Return on Assets (ROA) | -21.42% | -21.42% | -23.57% | -26.63% | -26.14% | -13.99% | |
| Return on Capital Employed (ROCE) | -35.00% | -35.00% | -33.50% | -41.10% | -53.70% | -24.90% | |
| Earnings Yield | -12.78% | -8.26% | -30.11% | -12.61% | -106.63% | -19.11% | |
| FCF Yield | -11.54% | -7.46% | -24.30% | -10.93% | -83.88% | -14.05% | |
| Buyback Yield / Dilution | -48.11% | -48.11% | -29.83% | -13.13% | -1.19% | -462.91% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.